Literature DB >> 9686578

TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.

A C Grammer1, J L Swantek, R D McFarland, Y Miura, T Geppert, P E Lipsky.   

Abstract

CD40 engagement induces a variety of functional outcomes following association with adaptor molecules of the TNF receptor-associated factor (TRAF) family. Whereas TRAF2, -5, and -6 initiate NF-kappaB activation, the outcomes of TRAF3-initiated signaling are less characterized. To delineate CD40-induced TRAF3-dependent events, Ramos B cells stably transfected with a dominant negative TRAF3 were stimulated with membranes expressing recombinant CD154/CD40 ligand. In the absence of TRAF3 signaling, activation of p38 and control of Ig production were abrogated, whereas Jun N-terminal kinase activation and secretion of IL-10, lymphotoxin-alpha, and TNF-alpha were partially blocked. By contrast, induction of apoptosis, activation of NF-kappaB, generation of granulocyte-macrophage CSF, and up-regulation of CD54, MHC class II, and CD95 were unaffected by the TRAF3 dominant negative. Together, these results indicate that TRAF3 initiates independent signaling pathways via p38 and JNK that are associated with specific functional outcomes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  CD40 signaling in human dendritic cells is initiated within membrane rafts.

Authors:  P O Vidalain; O Azocar; C Servet-Delprat; C Rabourdin-Combe; D Gerlier; S Manié
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 2.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 3.  Multiple roles of TRAF3 signaling in lymphocyte function.

Authors:  Gail A Bishop; Ping Xie
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells.

Authors:  Youcun Qian; Zhendong Zhao; Zhengfan Jiang; Xiaoxia Li
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

5.  Molecular basis for CD40 signaling mediated by TRAF3.

Authors:  C Z Ni; K Welsh; E Leo; C K Chiou; H Wu; J C Reed; K R Ely
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals.

Authors:  Amrie C Grammer; Randy Fischer; Olivia Lee; Xuan Zhang; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2004-02-05       Impact factor: 5.156

7.  Germinal center kinase-like kinase (GLK/MAP4K3) expression is increased in adult-onset Still's disease and may act as an activity marker.

Authors:  Der-Yuan Chen; Huai-Chia Chuang; Joung-Liang Lan; Yi-Ming Chen; Wei-Ting Hung; Kuo-Lung Lai; Tse-Hua Tan
Journal:  BMC Med       Date:  2012-08-06       Impact factor: 8.775

8.  Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.

Authors:  Ping Xie; Bruce S Hostager; Gail A Bishop
Journal:  J Exp Med       Date:  2004-02-23       Impact factor: 14.307

9.  Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD.

Authors:  Nadine Hövelmeyer; F Thomas Wunderlich; Ramin Massoumi; Charlotte G Jakobsen; Jian Song; Marcus A Wörns; Carsten Merkwirth; Andrew Kovalenko; Monique Aumailley; Dennis Strand; Jens C Brüning; Peter R Galle; David Wallach; Reinhard Fässler; Ari Waisman
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

10.  Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.

Authors:  Pi-Xiao Wang; Xiao-Jing Zhang; Pengcheng Luo; Xi Jiang; Peng Zhang; Junhong Guo; Guang-Nian Zhao; Xueyong Zhu; Yan Zhang; Sijun Yang; Hongliang Li
Journal:  Nat Commun       Date:  2016-02-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.